What is Omkar Pharmachem share price return in the past 10 years?

Omkar Pharmachem Ltd share price has appreciated 14.5% annually (CAGR) over the past ten years.

Omkar Pharmachem Ltd - Stock Valuation and Financial Performance

Name: Omkar Pharmachem
Brand: Omkar Pharmachem

BSE: 532167 | NSE: | Pharmaceuticals & Drugs | Small Cap

Place order

Omkar Pharmachem Share Price

₹22.40 0.00 0.00%
as on 10-Apr'24 16:00

DeciZen - make an informed investing decision on Omkar Pharmachem

Based on:

Data

M-Cap below 100cr DeciZen not available

Omkar Pharmachem stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

114.67

Market Cap:

22.6 Cr.

52-wk low:

18.4

52-wk high:

26.3

Is Omkar Pharmachem Ltd an attractive stock to invest in?

1. Is Omkar Pharmachem Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Omkar Pharmachem Ltd is a below average quality company.

2. Is Omkar Pharmachem Ltd undervalued or overvalued?

The key valuation ratios of Omkar Pharmachem Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Omkar Pharmachem Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Omkar Pharmachem Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Omkar Pharmachem:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
ROCE % ⓘ	0%	-0.7%	-1.3%	-1.3%	-2.6%	-4.2%	-2.4%	2.8%	2.3%	2.4%	-
Value Creation Index ⓘ	-1.0	-1.1	-1.1	-1.1	-1.2	-1.3	-1.2	-0.8	-0.8	-0.8	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	0.1	0	0	0	0	0	0.1	0.3	0.5	0.5	0
Sales YoY Gr.	-	-100%	NA	NA	NA	NA	NA	440%	100%	0%	-
Adj EPS ⓘ	0	-0.1	-0.1	-0.1	-0.3	-0.4	-0.3	0.2	0.2	0.2	0.2
YoY Gr.	-	NA	NA	NA	NA	NA	NA	NA	-18.2%	11.1%	-
BVPS (₹) ⓘ	9.3	9.2	9.1	9.3	9.1	8.6	8.4	8.6	8.8	9	9.2
Adj Net Profit ⓘ	0	-0.1	-0.1	-0.1	-0.3	-0.4	-0.3	0.2	0.2	0.2	0
Cash Flow from Ops. ⓘ	0	-0.1	0.3	-0.8	-0.3	-0.3	-0.2	0	0.2	0.3	-
Debt/CF from Ops. ⓘ	0.7	-0.3	0	0	-1	-1.9	-4.1	40.3	4.6	2.3	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	25.5%	NA	121%	0%
Adj EPS ⓘ	NA	NA	NA	11.1%
BVPSⓘ	-0.4%	-0.2%	2.3%	2.3%
Share Price	14.5%	10.8%	2.7%	-10.4%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
Return on Equity % ⓘ	0	-0.7	-1.3	-1.3	-2.8	-4.7	-3	2.6	2.1	2.2	2.2
Op. Profit Mgn % ⓘ	5.4	0	0	0	0	0	-454.2	8.1	49.8	57.6	NAN
Net Profit Mgn % ⓘ	5.7	0	0	0	0	0	-576.9	82	33.9	36.6	INF
Debt to Equity ⓘ	0	0	0	0	0	0.1	0.1	0.1	0.1	0.1	-
Working Cap Days ⓘ	545	0	0	0	0	0	73	30	37	71	0
Cash Conv. Cycle ⓘ	341	0	0	0	0	0	10	-43	-18	-12	0

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 121.04%

Return on Equity has declined versus last 3 years average to 2.20%

Net Profit has been subdued in last 3 years 0.00%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials - Omkar Pharmachem Ltd.

	Standalone	Consolidated
TTM EPS (₹)	0.2	-
TTM Sales (₹ Cr.)	0	-
BVPS (₹.) ⓘ	9.2	-
Reserves (₹ Cr.) ⓘ	-1	-
P/BV ⓘ	2.44	-
PE ⓘ	114.67	-

From the Market
52 Week Low / High (₹)	18.43 / 26.25
All Time Low / High (₹)	1.50 / 26.25
Market Cap (₹ Cr.)	22.6
Equity (₹ Cr.)	10.1
Face Value (₹)	10
Industry PE ⓘ	47.5

Management X-Ray of Omkar Pharmachem:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Omkar Pharmachem

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Omkar Pharmachem

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Sales	0.07	0	0	0	0	0	0.05	0.27	0.54	0.54
Operating Expenses ⓘ	0.07	0.06	0.12	0.22	0.24	0.38	0.25	0.25	0.27	0.23
Manufacturing Costs	0	0	0	0	0	0	0	0	0	0
Material Costs	0	0	0	0	0	0	0	0	0	0
Employee Cost	0.02	0.02	0.03	0.14	0.14	0.19	0.15	0.15	0.17	0.14
Other Costs ⓘ	0.04	0.04	0.09	0.08	0.10	0.19	0.10	0.10	0.10	0.09
Operating Profit ⓘ	0	-0.06	-0.12	-0.22	-0.24	-0.38	-0.20	0.02	0.27	0.31
Operating Profit Margin (%)	5.4%	-	-	-	-	-	-454.0%	8.1%	49.8%	57.6%
Other Income ⓘ	0	0	0	0.01	0	0	0	0	0	0
Interest ⓘ	0	0	0	0	0.01	0.04	0.05	0.06	0.06	0.05
Depreciation ⓘ	0	0	0	0	0	0	0	0	0	0
Exceptional Items ⓘ	0	0	0	0.48	0	0	0	0	0	0
Profit Before Tax ⓘ	0	-0.06	-0.12	0.27	-0.25	-0.42	-0.26	-0.04	0.21	0.26
Tax ⓘ	0	0	0	0.05	0	0	0	-0.26	0.03	0.07
Profit After Tax	0	-0.06	-0.12	0.22	-0.26	-0.42	-0.26	0.22	0.18	0.20
PAT Margin (%)	5.7%	-	-	-	-	-	-576.0%	82.0%	33.9%	36.6%
Adjusted EPS (₹)	0.0	-0.1	-0.1	0.2	-0.3	-0.4	-0.3	0.2	0.2	0.2
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Equity and Liabilities
Shareholders Fund	9.34	9.27	9.16	9.38	9.12	8.70	8.44	8.66	8.85	9.04
Share Capital ⓘ	10.08	10.08	10.08	10.08	10.08	10.08	10.08	10.08	10.08	10.08
Reserves ⓘ	-0.75	-0.81	-0.93	-0.71	-0.96	-1.38	-1.64	-1.42	-1.24	-1.04
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	0.01	0.01	0	0	0.24	0.58	0.87	0.90	0.93	0.62
Long Term Debt	0.01	0.01	0	0	0	0	0	0	0	0
Short Term Debt	0	0	0	0	0.24	0.58	0.87	0.90	0.93	0.62
Trade Payables	0.01	0.02	0.04	0.03	0.02	0.02	0.03	0.03	0.02	0.04
Others Liabilities ⓘ	0.09	0.10	0.52	0.02	0.02	0.02	0.02	-0.22	-0.20	-0.14
Total Liabilities ⓘ	9.45	9.40	9.72	9.43	9.40	9.32	9.36	9.37	9.60	9.57
Fixed Assets
Gross Block	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.02	0.02
Accumulated Depreciation	0	0	0	0	0	0.01	0.01	0.01	0.01	0.02
Net Fixed Assetsⓘ	0.01	0.01	0.01	0	0.01	0	0	0	0.01	0
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0
Investmentsⓘ	9.30	9.30	9.30	9.30	9.30	9.30	9.30	9.30	9.30	9.30
Inventories	0	0	0	0	0	0	0	0	0	0
Trade Receivables	0.07	0.07	0.07	0.07	0.07	0	0.02	0.03	0.08	0.13
Cash Equivalents	0.05	0	0.33	0.05	0.02	0.02	0.04	0.04	0.21	0.13
Others Assetsⓘ	0.02	0.01	0	0	0	0	0	0	0	0
Total Assets ⓘ	9.45	9.40	9.72	9.43	9.40	9.32	9.36	9.37	9.60	9.57

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Cash Flow From Operating Activity ⓘ	0.02	-0.05	0.34	-0.77	-0.25	-0.30	-0.21	0.02	0.20	0.28
PBT ⓘ	0	-0.06	-0.12	-0.21	-0.25	-0.42	-0.26	-0.04	0.21	0.26
Adjustment ⓘ	0	0	0	0	0.02	0.12	0.05	0.06	0.06	0.05
Changes in Working Capital ⓘ	0.01	0.01	0.46	-0.51	-0.01	0.01	-0.01	0	-0.07	-0.04
Tax Paid ⓘ	0	0	0	-0.05	0	0	0	0	0	0
Cash Flow From Investing Activity ⓘ	0	0	0	0.49	-0.01	0	0	0	-0.01	0
Capex	0	0	0	0.49	-0.01	0	0	0	-0.01	0
Net Investments	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0	0	0	0	0	0	0	0	0
Cash Flow From Financing Activityⓘ	0	0	-0.01	0.01	0.23	0.30	0.24	-0.02	-0.03	-0.35
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	0	0	0	0.01	-0.01	-0.04	-0.05	-0.06	-0.06	-0.05
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0	-0.01	0	0.24	0.34	0.29	0.04	0.03	-0.31
Net Cash Flow ⓘ	0.02	-0.05	0.33	-0.28	-0.03	0	0.02	0	0.17	-0.08

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Ratios
ROE (%)	0.04	-0.66	-1.27	2.38	-2.77	-4.72	-3.03	2.59	2.09	2.21
ROCE (%)	0.04	-0.66	-1.27	2.91	-2.55	-4.11	-2.22	0.22	2.76	3.2
Asset Turnover Ratio	0.01	0	0	0	0	0	0	0.03	0.06	0.06
PAT to CFO Conversion(x)	N/A	N/A	N/A	-3.5	N/A	N/A	N/A	0.09	1.11	1.4
Working Capital Days
Receivable Days	464	0	0	0	0	0	146	30	37	71
Inventory Days	0	0	0	0	0	0	0	0	0	0
Payable Days	0	0	0	0	0	0	0	0	0	0

Omkar Pharmachem Ltd Stock News

Omkar Pharmachem Ltd FAQs

What is the share price of Omkar Pharmachem?

Company share prices are keep on changing according to the market conditions. The closing price of Omkar Pharmachem on 10-Apr-2024 16:00 is ₹22.40.

What is the market cap of Omkar Pharmachem?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 10-Apr-2024 16:00 the market cap of Omkar Pharmachem stood at ₹22.59.

What is the P/E ratio of Omkar Pharmachem?

The latest P/E ratio of Omkar Pharmachem as of 10-Apr-2024 16:00 is 114.7.

What is the P/B ratio of Omkar Pharmachem?

The latest P/B ratio of Omkar Pharmachem as of 10-Apr-2024 16:00 is 2.44.

What is the 52-week high and low of Omkar Pharmachem?

The 52-week high of Omkar Pharmachem is ₹26.25 and the 52-week low is ₹18.43.

What is the TTM revenue of Omkar Pharmachem?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Omkar Pharmachem is ₹0.00 ( Cr.) .

About Omkar Pharmachem Ltd

Omkar Pharmachem was incorporated in 1994, it is located in New Delhi. The manufacturing unit developed the capacity to manufacture sodium bi-sulphite, sodium meta bi-sulphite, sodium sulphite, and sulphur.

In the financial year 2007, the company did not conduct any manufacturing or other business activity due to tough market conditions. It has further decided to discontinue commercial activity and wait till an appropriate business environment is established.

The registered office of the company is located at Mahakant Building, 501, Ashram Road opposite V S Hospital Ellisbridge Ahmedabad, Gujarat 380006.

Business area of the company

The company is engaged in the manufacturing of pharmaceutical chemicals.